Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2013

The Active Network, Inc. (ACTV) Video Chart for Friday, April 5, 2013

Posted on April 5, 2013 by MissionIR

A classic bottom play, ACTV has suffered a large fall in the last year from above $15 to $4. The chart is showing a positive divergence between the MACD and PPS, giving hints that a move is possible off the … Continue reading →

Posted in Technical Analysis | Leave a comment

Cardium Therapeutics, Inc. (CXM) Reports 2012 Financial Results, Recent Developments, and Financing

Posted on April 5, 2013 by MissionIR

Today before the opening bell, Cardium made a series of announcements as well as provided a comprehensive update on its ongoing initiatives. An abridged overview is presented below due to the length of the press releases issued. For detailed information, … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Accuray, Inc. (ARAY) Reports First Patients Treated with New TomoEDGE Dynamic Jaws Technology

Posted on April 5, 2013 by MissionIR

Accuray is a radiation oncology company that develops, manufactures, and sells personalized, innovative treatment solutions. The company’s leading-edge technologies deliver a full range of radiation therapy and radiosurgery treatments, helping patients to live longer, better lives. The company announced that … Continue reading →

Posted in Small Cap News | Leave a comment

India Globalization Capital, Inc. (IGC) Completes Minority Interest Acquisition of TBL

Posted on April 5, 2013 by MissionIR

Yesterday, India Globalization Capital announced that on March 31, it completed its acquisition of the remaining 23.13% of the TBL shares still owned by the Founders of TBL. This previously announced acquisition was completed for around $185,000. As per the … Continue reading →

Posted in Small Cap News | Leave a comment

Case Summary for VistaGen Therapeutics, Inc. (VSTA)

Posted on April 4, 2013 by MissionIR

VistaGen Therapeutics is a California biotechnology company focused primarily on the use of its proprietary pluripotent stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. The core of the company’s strategy is … Continue reading →

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

SMTP, Inc. (SMTP) Posts FY2012 Financial Results, Names New Members to Operations Team

Posted on April 4, 2013 by MissionIR

SMTP, a provider of cloud-based services to facilitate e-mail deliverability, has announced financial results for the year ended December 31, 2012, as well as announced the appointment of new members to a three-member oversight committee. Total revenues for the year … Continue reading →

Posted in Small Cap News | Leave a comment

Mitel Networks Corp. (MITL) Announces Release of Cloud-Based Contact Center Solution for Small and Mid-Size Businesses

Posted on April 4, 2013 by MissionIR

Mitel, a leading provider of cloud and premises-based unified communications software solutions, yesterday announced the release of its Mitel AnyWare Cloud Contact Center solution at the Cloud Connect Conference. Mitel’s Cloud Contact Center solution comes as the latest addition to … Continue reading →

Posted in Small Cap News | Leave a comment

Intellipharmaceutics International, Inc. (IPCI) Closes on $3.1 Million Unit Offering

Posted on April 4, 2013 by MissionIR

Intellipharmaceutics International is a pharmaceutical company specializing in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The company’s patented Hypermatrix technology is a controlled-release drug delivery platform that can be applied to … Continue reading →

Posted in Small Cap News | Leave a comment

Antares Pharma, Inc. (ATRS) Completes First Shipment of Commercial VIBEX Auto-Injector Devices to Teva

Posted on April 4, 2013 by MissionIR

Antares Pharma announced that the first shipment of commercial-ready VIBEX auto-injector devices was sent to Teva at the end of 2013’s first quarter. This initial order of prelaunch quantities of VIBEX, a generic epinephrine auto-injector, is the first of many … Continue reading →

Posted in Small Cap News | Leave a comment

Astea International Inc. (ATEA) Teams Up with Capgemini to Produce a Cloud-Driven Field Service Management Platform

Posted on April 3, 2013 by MissionIR

Astea International is reporting the launch of Astea Alliance as a service today. Astea Alliance combines the consulting, technology, and outsourcing services capability of the Capgemini cloud platform with the company’s own service lifecycle management ecosystem to offer users a … Continue reading →

Posted in Small Cap News | Leave a comment